On June 11, 2022 Oxford Drug Design reported that it will be attending the 28th tRNA Conference, 12-16 June 2022 in Columbus, Ohio, USA (Press release, Oxford Drug Design, JUN 11, 2022, View Source [SID1234615907]). On 13 June at 4:45pm EST Paul will be participating in a Panel Discussion on "Emerging Opportunities in tRNA Therapeutics", which will showcase the emerging opportunities for translational science and entrepreneurism in tRNA-related therapeutics and biotechnology across multiple therapeutic areas and treatment modalities. This is an exciting area with untapped therapeutic potential in which Oxford Drug Design is taking a leading position.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!